Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F7VL8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $81,514
Award facts
- Contract value 100% obligated
- $81,514.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $81,514.36 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, awarded on January 28, 2026, with an ultimate completion date of January 29, 2026, represents a non-competitive award under a larger contract vehicle. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used to treat high cholesterol in patients at risk for cardiovascular disease, reflecting the breadth of pharmaceutical products supplied through federal medical procurement channels.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2031. This primary contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and medical devices. The parent company competes on a full and open basis for federal pharmaceutical contracts and serves critical healthcare needs across the Defense Health Agency, U.S. Coast Guard, and other government medical institutions.
Quick answers
Who was awarded contract SPE2DR26F7VL8?
SPE2DR26F7VL8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F7VL8 worth?
The government has obligated $81,514 on SPE2DR26F7VL8.
Is contract SPE2DR26F7VL8 an order under another contract?
Yes. SPE2DR26F7VL8 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VL8 competed?
The extent of competition for SPE2DR26F7VL8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award